SSA
VIRX

Schonfeld Strategic Advisors’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History

Schonfeld Strategic Advisors’s Portfolio VIRX Stock Details VIRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-10,800
Closed -$42K – 3106
2022
Q2 		$42K Sell
10,800
-4,300
-28% -$16.7K ﹤0.01% 2166
2022
Q1 		$72K Buy
+15,100
New +$72K ﹤0.01% 2226